The American Reporter
Tuesday, September 15, 2026
  • Login
  • World
  • National
  • Science
  • Business
  • Health
  • Education
  • Lifestyle
  • Entertainment
  • Sports
  • Technology
No Result
View All Result
  • World
  • National
  • Science
  • Business
  • Health
  • Education
  • Lifestyle
  • Entertainment
  • Sports
  • Technology
No Result
View All Result
The American Reporter
No Result
View All Result

New Tech Revolutionizes Overactive Bladder Treatment

Jennifer Ross by Jennifer Ross
June 17, 2021
in Health
New Tech Revolutionizes Overactive Bladder Treatment
892
VIEWS
Share on FacebookShare on Twitter

Revolutionizing, new technology might change everything for people who suffer from overactive bladder. BlueWind Medical’s new device, the RENOVA™ iStim, is small, minimally invasive, and already having positive effects. This patient centric, home based therapy could be suitable for many patients as a way to reduce or completely end symptoms related to overactive bladder (OAB). 

Those who suffer from overactive bladder already know the frustrating symptoms that come with it: sudden, intense urges to urinate, or the fear that they may involuntarily urinate if they don’t go to the restroom right away. Even worse, people with OAB might even accidentally leak urine when those sudden urges start to spike, or they might simply have to use the restroom far more often than normal.

These symptoms are more than frustrating or anxiety inducing, they’re embarrassing. Needing to constantly be aware of where to find the nearest restroom and having to frequently interrupt activities can leave people with OAB feeling like a burden when spending time with friends or family, and that stress is magnified when the urges interrupt professional meetings or important events.

What’s interesting is that, while many of those who have OAB feel embarrassment for it, OAB is actually surprisingly common. According to the American Urological Association, more than 33 million Americans have OAB, with one-third of all Americans aged 40 and over reporting that they have some level of urinary incontinence “at least sometimes.”

Despite the fact that OAB is such a widely experienced, commonplace problem, nearly half of all patients refuse to seek treatment. Reasons often come from embarrassment or shame, but also because the treatment that exists either doesn’t fully work, or else they demand a major sacrifice of the patient’s time and money. Physical training, such as Kegel exercises, and dietary changes can also occasionally help, but again, the results aren’t guaranteed. More invasive treatments exist, but all have their own drawbacks: Botox injections can deaden surface nerves of the bladder but require repeated treatments, Sacral Nerve Modulation (SNM) devices are large and require an invasive lower back surgery under full anesthesia. Percutaneous Tibial Nerve Modulation (PTNM) therapy requires weekly visits to a clinic to administer treatment.

BlueWind’s RENOVA™ iStim, however, is looking to usher in an entire new age of OAB treatment. Tiny and cutting out the need for frequent trips to the doctor, the RENOVA™ iStim is truly a revolution in the field of OAB treatment. Just over an inch long and a fraction of that in circumference, the RENOVA™ stimulator is implanted in a patient’s ankle in a simple procedure under local anesthesia. With the tiny stimulator in place, patients are able to perform Tibial Nerve Modulation (TNM) therapy treatments from the comfort and privacy of their own home using an ankle bracelet that wirelessly connects to the implanted stimulator. Patients wear the bracelet to initiate therapy for only 30 minutes, twice a day. The bracelet is lightweight and the patient can walk around and continue with their daily life while the device is stimulating.

This technology is revolutionary not only in the far-less invasive surgical procedure needed to implant the stimulator, but also for the simple fact that patients won’t need to frequent doctors’ offices as often. The stimulator’s smaller size and lack of wiring also means far fewer complications concerning shifting or infection, which leads to some patients using the current SNM technology to have to return for additional surgical procedures.

It feels like science fiction, but the results speak for themselves. From their initial study group, BlueWind found that 71% of patients in the pilot study using the RENOVA™ iStim have experienced at least a 50% decline in OAB symptoms, and 28% of their patients became “dry,” experiencing an entire stoppage to all leaking. The company is in the process of running a pivotal study with the hope of receiving FDA marketing clearance within the next two years.

The RENOVA™ iStim system’s patient-focused tech allowing the freedom of at-home treatment, a far simpler implantation procedure, and wireless treatment and battery charging certainly reveals that the future of OAB treatment is being changed in a revolutionary way.

A new day is coming, and BlueWind’s innovation is paving the way to freedom from OAB. Learn more about Bluewind Medical and the RENOVA™ iStim by visiting BluewindMedical.com

To see if you are eligible to participate in the study, please visit oasisoabstudy.com for qualification information.

Follow Bluewind Medical on social media: @bluewindmedical

Disclaimer: Investigational device. Limited by Federal or United States) law to investigational us.

Previous Post

Melanie Verstraete Is The Mastermind Teaching People How To Find Their Hidden Power. Here’s How You Can Step Forward Confidently Too

Next Post

Modest Personality, Ni’anah, is a Fashion Designer who is Making New Milestones in the Entrepreneurial World

Next Post
Modest Personality, Ni’anah, is a Fashion Designer who is Making New Milestones in the Entrepreneurial World

Modest Personality, Ni'anah, is a Fashion Designer who is Making New Milestones in the Entrepreneurial World

Latest News

HKEX-listed chairman funded failed bid to uphold will that promised him HK$1.92 billion

HKEX-listed chairman funded failed bid to uphold will that promised him HK$1.92 billion

September 15, 2026

The Difference Between Looking Wealthy And Being Financially Resilient

September 11, 2026

Fratarcangeli Wealth Management: Why Election-Year Volatility Should Be Treated as Opportunity, Not Just Risk

September 10, 2026

Manmin Church Marks 25th Bible Quiz Contest

September 7, 2026

John Martinkat Discusses the Future of International Tax Planning

September 4, 2026

Why Enterprises Are Rethinking Data Security in the Age of AI Agents

September 3, 2026

Tajel Shah Discusses Building Effective SOPs: Foundational Strategies for Administrative Excellence

September 2, 2026

The Best Ballet Classes in Melbourne for 2026

September 2, 2026

MAXIMILIEN SCHMITT: “My creative path has been a fragile equilibrium between constant change and strong commitment.”

September 2, 2026

Denis Kitaev, his Rethinking of Luxury Living, and the Ideas Behind Vesper

September 2, 2026

The Moment Money Stops Feeling Like a Problem and Starts Feeling Like Power

September 1, 2026

Matthew Fleeger’s Investment Thesis on Downturns

September 1, 2026
  • Home
  • About Us
  • Our Staff
  • Contact Us
  • Privacy Policy
  • Editorial Policy
  • Use of Cookies

© 2019 - The American Reporter

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • About Us
  • Our Staff
  • Contact Us
  • Privacy Policy
  • Editorial Policy
  • Use of Cookies

© 2019 - The American Reporter

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.